DOCSLIB.ORG

Phospholipid Signalling: Rho Is Only ARF the Story Michael A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Phospholipid Signalling: Rho Is Only ARF the Story Michael A View metadata, citation and similar papers at core.ac.uk brought to you by CORE providedDispatch by Elsevier -945 Publisher Connector Phospholipid signalling: Rho is only ARF the story Michael A. Frohman and Andrew J. Morris The GTP-binding proteins ARF and Rho control a short to involve alterations in gene expression, indicating number of important cellular processes, such as protein that these events must be controlled through other regula- traffic and cell morphology; there is increasing evidence tory pathways. Thus, Rho proteins, like ARFs, regulate that phospholipase D is a key mediator of these complex processes in cells and in both cases the precise ARF/Rho-regulated events. steps and mechanisms involved have been unclear. Address: Department of Pharmacological Science and Institute for Cell and Molecular Biology, State University of New York, Stony Brook, That PLD is activated following agonist stimulation has New York 11794-8651, USA. been observed in numerous cell types and with a wide variety of ligands acting via G-protein-coupled receptors or Current Biology 1996, Vol 6 No 8:945–947 receptor tyrosine kinases. While investigating the mecha- © Current Biology Ltd ISSN 0960-9822 nism of PLD activation, several groups observed PLD activities in tissues and cell lines that showed guanine- Small GTP-binding proteins act as switches that control nucleotide dependence, which was subsequently shown to diverse cellular processes. Those in the ADP-ribosylation be mediated by members of the ARF and Rho families. factor (ARF) class direct key steps in intracellular protein Two groups used different approaches to identify ARF as traffic, whereas those in the Rho family regulate gene tran- a GTP-dependent regulator of PLD activity [8,9]. Their scription as well as changes in cell motility and morphology observations were initially made using HL-60 cells as the [1,2]. Several groups have now produced evidence that source of PLD activity, but PLD enzymes with similar these regulatory activities of Rho and ARF proteins may be sensitivity to ARF stimulation (presumably identical or mediated by phosphatidylcholine (PC)-specific phospholi- closely related enzymes) are expressed in other tissues. pase D (PLD). PLD generates phosphatidic acid (PA), The GTP-dependent activation of PLD in neutrophils is which may be an intracellular mediator in its own right and apparently mediated by Rho [10]; furthermore, two Rho- which can be metabolized to form lipids with proven roles related G proteins, Rac1 and Cdc42, can also stimulate as both intercellular and intracellular messengers [3]. several mammalian PLD activities independently of (and synergistically with) other regulators [11,12]. ARF and Rho regulation of PLD activity ARFs were initially identified as activators of cholera toxin We have recently reported [13] the cloning and expression ADP-ribosyl transferase activity towards the a subunit of of the human gene encoding PLD1, a G-protein-regulated the heterotrimeric G protein Gs. There are six mammalian PLD. ARF1, and the Rho proteins RhoA, Rac1 and Cdc42, ARFs, which are largely soluble but can bind to mem- all activate purified PLD1; the purified enzyme can also be branes in a regulated and GTP-dependent manner. ARFs activated by protein kinase Ca in a novel, kinase-indepen- play an essential role in intracellular membrane traffic, and dent manner. The G-protein activators are approximately have been implicated in both ER-to-Golgi and intra-Golgi equipotent, and the three classes of regulators — ARF, Rho vesicle transport. Reconstitution studies using mammalian and PKC — activate PLD1 synergistically, suggesting that systems have demonstrated that ARF1 regulates the they interact with different sites on the enzyme (our unpub- assembly of the coat protein complex — the coatomer or lished data). Several lines of evidence have suggested the COP — which controls the budding of transport vesicles existence of additional mammalian PLDs (reviewed in from Golgi cisternae [4,5] and presumably also from ER [14]), and our group has recently identified a second mam- membranes. Why there are multiple ARFs is poorly malian PLD, PLD2, which, like PLD1, requires phos- understood, but their existence is presumably important; phatidylinositol 4,5-bisphosphate (PIP2) for activity in vitro ARF6, for example, localizes to the plasma membrane and (unpublished data). Mammalian tissues also contain PIP2- regulates receptor-mediated endocytosis [6]. independent PLD activities which are stimulated by fatty acids such as oleate [15]. It is not known how many mam- Rho family proteins play dynamic roles in the regulation malian PLD enzymes there are, though our molecular of the actin cytoskeleton, thereby controlling various studies [13], which have revealed the existence of a PLD aspects of cell morphology and motility, depending on the multigene family, should help clarify this important issue. particular Rho protein involved. Thus, Rac is required for membrane ruffling and Rho for formation of stress fibers, What is the function of PLD-generated PA? and Cdc42 regulates the formation of actin-containing Understanding the role of PLD in cellular regulation by microspikes called filopodia [7]. The effects of Rho pro- the ARF and Rho proteins will require identification of the teins in microinjected cells occur on a time scale that is too cellular targets and functions of its reaction product, PA. 946 Current Biology 1996, Vol 6 No 8 PA can clearly be metabolized to generate both intracellu- Rothman and colleagues [4] reported that coatomer lar and extracellular messengers — diacylglycerol, arachi- assembly can be reconstituted in washed Golgi membrane donic acid and lysophosphatidic acid (reviewed in [14]) — preparations with the addition of just ARF and coatomer. but it is beginning to appear equally likely that it is also an It is likely, however, that PLD was present in these exper- intracellular mediator in its own right. For example, iments, as it is tightly associated with membranes and several identified (Raf and certain PKC isoforms) and present in significant amounts in the Golgi apparatus [21]. unidentified protein kinases have been reported to be acti- Sternweis, Roth and colleagues [21,22] have begun to vated by PA in vitro [16], although the physiological impor- establish that ARF-activated PLD does indeed have an tance of this type of regulation requires further study [3]. important role in intracellular protein traffic. They have found that ARF-activated PLD is enriched in Golgi mem- As no selective PLD inhibitors have been discovered, branes, and provided several lines of evidence that PA attempts to generate direct evidence supporting in vivo formed through ARF stimulation of PLD plays an impor- roles for PLD-generated PA have entailed the direct tant role in coatomer binding. This suggests the model administration of PA itself to cells, or the use of primary shown in Figure 1, in which activation of Golgi-mem- alcohols which are used as substrates by PLD for a brane-associated PLD1 by ARF leads to recruitment of transphosphatidylation reaction which generates phos- the cytosolic coatomer complex, and consequent alter- phatidylalcohols instead of PA. Exogenously added PA ations in membrane structure leading to vesicle budding. has been shown to increase, and primary alcohols to inhibit, actin polymerization leading to stress-fiber forma- The synergistic effect of Rho on ARF stimulation of PLD1 tion in endothelial cells, suggesting a role for PLD as a activity in vitro suggests that this enzyme may act as an mediator of cytoskeletal reorganization [17]. Primary alco- integrative regulator of both constitutive secretion, pre- hols have also been used to demonstrate that secretion by sumably under the control of ARF, and receptor-regulated HL-60 cells and neutrophils is blocked when PA produc- tion is inhibited, supporting the hypothesis that PLD Figure 1 plays a role in secretion [18,19]. Caveats should be applied, however, to the interpretation of Agonists both of these experimental approaches. PA is normally pro- duced intracellularly by PLD, and it is not clear that exoge- Receptors nously applied PA exerts its actions through normal physiological pathways (as opposed, for example, to stimu- Coated vesicle lating receptors on the cell surface, as lysophosphatidic acid PLC is known to do). And although phosphatidylalchohols Budding ? ? appear to be metabolically inert, they may nonetheless acti- COP vate some PA-dependent processes to an unknown extent. Moreover, the relatively high concentrations of alcohols PKC used in these types of experiment may influence these or other cellular responses through different mechanisms. COP The role of PLD1 in ARF and Rho-regulated processes GTP Rho PLD1 Given the evidence presented above, it has been tempting ARF GTP to speculate that PLD activation by ARF and Rho reflects PiP2 roles for distinct PLDs in separate pathways — secretion PC PA and signal transduction, respectively. The finding that Golgi PLD1 is regulated by both ARF and Rho, however, sup- membrane Priming Vesiculation ports a blurring of this distinction and suggests that the © Current Biology 1996 two processes may be more integrated than previously rec- ognized. Several lines of evidence support this idea. For PLD1- and ARF-dependent formation of coated vesicles. PLD1 example, most ARF is found in the cytosol in HL-60 cells participates in the ‘priming’ step of coated vesicle formation by [20]; immediately after stimulation with a ligand
Load more

Recommended publications
  • An Arf1 Synthetic Lethal Screen Identifies a New Clathrin Heavy
    Copyright 1998 by the Genetics Society of America An arf1D Synthetic Lethal Screen Identi®es a New Clathrin Heavy Chain Conditional Allele That Perturbs Vacuolar Protein Transport in Saccharomyces cerevisiae Chih-Ying Chen and Todd R. Graham Department of Molecular Biology, Vanderbilt University, Nashville, Tennessee 37235 Manuscript received March 5, 1998 Accepted for publication June 16, 1998 ABSTRACT ADP-ribosylation factor (ARF) is a small GTP-binding protein that is thought to regulate the assembly of coat proteins on transport vesicles. To identify factors that functionally interact with ARF, we have performed a genetic screen in Saccharomyces cerevisiae for mutations that exhibit synthetic lethality with an arf1D allele and de®ned seven genes by complementation tests (SWA1-7 for synthetically lethal with arf1D). Most of the swa mutants exhibit phenotypes comparable to arf1D mutants such as temperature-conditional growth, hypersensitivity to ¯uoride ions, and partial protein transport and glycosylation defects. Here, we report that swa5-1 is a new temperature-sensitive allele of the clathrin heavy chain gene (chc1-5), which carries a frameshift mutation near the 39 end of the CHC1 open reading frame. This genetic interaction between arf1 and chc1 provides in vivo evidence for a role for ARF in clathrin coat assembly. Surprisingly, strains harboring chc1-5 exhibited a signi®cant defect in transport of carboxypeptidase Y or carboxypepti- dase S to the vacuole that was not observed in other chc1 ts mutants. The kinetics of invertase secretion or transport of alkaline phosphatase to the vacuole were not signi®cantly affected in the chc1-5 mutant, further implicating clathrin speci®cally in the Golgi to vacuole transport pathway for carboxypeptidase Y.
    [Show full text]
  • ARF1 Dimerization Is Essential for Vesicle Trafficking and Dependent
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.21.913905; this version posted January 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 ARF1 dimerization is essential for vesicle trafficking and dependent on activation by ARF-GEF 2 dimers in Arabidopsis 3 4 Sabine Brumm1, Mads Eggert Nielsen1,2, Sandra Richter1, Hauke Beckmann1, York-Dieter Stierhof3, Manoj 5 K. Singh1, Angela-Melanie Fischer1, Venkatesan Sundaresan4, Gerd Jürgens1,* 6 7 1 Center for Plant Molecular Biology (ZMBP), Developmental Genetics, University of Tübingen, Auf der 8 Morgenstelle 32, 72076 Tübingen, Germany 9 2 University of Copenhagen, Faculty of Science, Section for Plant and Soil Science, Thorvaldsensvej 40, 10 1871 Frederiksberg C, Denmark 11 3 Center for Plant Molecular Biology (ZMBP), Microscopy, University of Tübingen, Auf der Morgenstelle 12 32, 72076 Tübingen, Germany 13 4 Department of Plant Biology and Department of Plant Sciences, University of California, Davis, One 14 Shields Avenue, Davis, CA 95616, USA 15 16 * Corresponding author: 17 Gerd Jürgens 18 Center for Plant Molecular Biology (ZMBP), Developmental Genetics, University of Tübingen, Auf der 19 Morgenstelle 32, 72076 Tübingen, Germany 20 Phone: +49-7071-2978886 21 Email: [email protected] 22 ORCID: 0000-0003-4666-8308 23 24 Short title 25 Activation-dependent ARF1 dimerization 26 27 Material distribution footnote 28 The author responsible for distribution of materials integral to the findings presented in this article is: 29 Gerd Jürgens ([email protected]).
    [Show full text]
  • Dissection of Gtpase-Activating Proteins Reveals Functional Asymmetry in the COPI Coat of Budding Yeast Eric C
    © 2019. Published by The Company of Biologists Ltd | Journal of Cell Science (2019) 132, jcs232124. doi:10.1242/jcs.232124 RESEARCH ARTICLE Dissection of GTPase-activating proteins reveals functional asymmetry in the COPI coat of budding yeast Eric C. Arakel1, Martina Huranova2,3,*, Alejandro F. Estrada2,*, E-Ming Rau2, Anne Spang2,‡ and Blanche Schwappach1,4,‡ ABSTRACT The COPI coat is formed by an obligate heptamer – also termed – α β′ ε β γ δ ζ The Arf GTPase controls formation of the COPI vesicle coat. Recent coatomer consisting of , , , , , and subunits, and is recruited structural models of COPI revealed the positioning of two Arf1 en bloc to membranes (Hara-Kuge et al., 1994). Fundamentally, the molecules in contrasting molecular environments. Each of these COPI coat mediates the retrograde trafficking of proteins and lipids pockets for Arf1 is expected to also accommodate an Arf GTPase- from the Golgi to the ER, and within intra-Golgi compartments activating protein (ArfGAP). Structural evidence and protein (Arakel et al., 2016; Beck et al., 2009; Pellett et al., 2013; Spang and interactions observed between isolated domains indirectly suggest Schekman, 1998). Several reports have also implicated COPI in that each niche preferentially recruits one of the two ArfGAPs known endosomal recycling and regulation of lipid droplet homeostasis to affect COPI, i.e. Gcs1/ArfGAP1 and Glo3/ArfGAP2/3, although (Aniento et al., 1996; Beller et al., 2008; Xu et al., 2017). only partial structures are available. The functional role of the unique Activation of the small GTPase Arf1 and its subsequent non-catalytic domain of either ArfGAP has not been integrated into membrane anchoring by exchanging GDP with GTP through a the current COPI structural model.
    [Show full text]
  • The Arf1p Gtpase-Activating Protein Glo3p Executes Its Regulatory Function Through a Conserved Repeat Motif at Its C-Terminus
    2604 Research Article The Arf1p GTPase-activating protein Glo3p executes its regulatory function through a conserved repeat motif at its C-terminus Natsuko Yahara1,*, Ken Sato1,2 and Akihiko Nakano1,3,‡ 1Molecular Membrane Biology Laboratory, RIKEN Discovery Research Institute and 2PRESTO, Japan Science and Technology Agency, Hirosawa, Wako, Saitama 351-0198, Japan 3Department of Biological Sciences, Graduate School of Science, University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan *Present address: Department of Biochemistry, University of Geneva, Sciences II, Geneva, Switzerland ‡Author for correspondence (e-mail: [email protected]) Accepted 21 March 2006 Journal of Cell Science 119, 2604-2612 Published by The Company of Biologists 2006 doi:10.1242/jcs.02997 Summary ADP-ribosylation factors (Arfs), key regulators of ArfGAP, Gcs1p, we have shown that the non-catalytic C- intracellular membrane traffic, are known to exert multiple terminal region of Glo3p is required for the suppression of roles in vesicular transport. We previously isolated eight the growth defect in the arf1 ts mutants. Interestingly, temperature-sensitive (ts) mutants of the yeast ARF1 gene, Glo3p and its homologues from other eukaryotes harbor a which showed allele-specific defects in protein transport, well-conserved repeated ISSxxxFG sequence near the C- and classified them into three groups of intragenic terminus, which is not found in Gcs1p and its homologues. complementation. In this study, we show that the We name this region the Glo3 motif and present evidence overexpression of Glo3p, one of the GTPase-activating that the motif is required for the function of Glo3p in vivo. proteins of Arf1p (ArfGAP), suppresses the ts growth of a particular group of the arf1 mutants (arf1-16 and arf1-17).
    [Show full text]
  • Phospholipase D in Cell Proliferation and Cancer
    Vol. 1, 789–800, September 2003 Molecular Cancer Research 789 Subject Review Phospholipase D in Cell Proliferation and Cancer David A. Foster and Lizhong Xu The Department of Biological Sciences, Hunter College of The City University of New York, New York, NY Abstract trafficking, cytoskeletal reorganization, receptor endocytosis, Phospholipase D (PLD) has emerged as a regulator of exocytosis, and cell migration (4, 5). A role for PLD in cell several critical aspects of cell physiology. PLD, which proliferation is indicated from reports showing that PLD catalyzes the hydrolysis of phosphatidylcholine (PC) to activity is elevated in response to platelet-derived growth factor phosphatidic acid (PA) and choline, is activated in (PDGF; 6), fibroblast growth factor (7, 8), epidermal growth response to stimulators of vesicle transport, endocyto- factor (EGF; 9), insulin (10), insulin-like growth factor 1 (11), sis, exocytosis, cell migration, and mitosis. Dysregula- growth hormone (12), and sphingosine 1-phosphate (13). PLD tion of these cell biological processes occurs in the activity is also elevated in cells transformed by a variety development of a variety of human tumors. It has now of transforming oncogenes including v-Src (14), v-Ras (15, 16), been observed that there are abnormalities in PLD v-Fps (17), and v-Raf (18). Thus, there is a growing body of expression and activity in many human cancers. In this evidence linking PLD activity with mitogenic signaling. While review, evidence is summarized implicating PLD as a PLD has been associated with many aspects of cell physiology critical regulator of cell proliferation, survival signaling, such as membrane trafficking and cytoskeletal organization cell transformation, and tumor progression.
    [Show full text]
  • Characterization of the Golgi C10orf76-PI4KB Complex, and Its
    bioRxiv preprint doi: https://doi.org/10.1101/634592; this version posted May 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 1 Characterization of the Golgi c10orf76-PI4KB complex, and its 2 necessity for Golgi PI4P levels and enterovirus replication 3 4 McPhail, J.A.1, Lyoo, H.R.2*, Pemberton, J.G.3*, Hoffmann, R.M.1, van Elst W.2, 5 Strating J.R.P.M.2, Jenkins, M.L.1, Stariha, J.T.B.1, van Kuppeveld, F.J.M.2#, Balla., T.3#, and 6 Burke, J.E.1# 7 * - These authors contributed equally 8 # - Corresponding authors 9 10 Affiliations 11 1 Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, 12 Canada 13 2 Department of Infectious Diseases & Immunology, Virology Division, Faculty of 14 Veterinary Medicine, Utrecht University, Utrecht, The Netherlands. 15 3 Section on Molecular Signal Transduction, Eunice Kennedy Shriver National Institute 16 of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 17 USA 18 19 Corresponding authors: 20 Burke, John E. ([email protected]), Tel: 1-250-721-8732 21 Balla, Tamas ([email protected]), Tel: 301-435-5637 22 van Kuppeveld, Frank J.M. ([email protected]), Tel: 31-30-253-4173 23 24 Running title 25 Role of c10orf76-PI4KB at the Golgi 26 27 28 29 30 31 32 bioRxiv preprint doi: https://doi.org/10.1101/634592; this version posted May 10, 2019.
    [Show full text]
  • Anti-ARFGAP3 Antibody (ARG63139)
    Product datasheet [email protected] ARG63139 Package: 100 μg anti-ARFGAP3 antibody Store at: -20°C Summary Product Description Goat Polyclonal antibody recognizes ARFGAP3 Tested Reactivity Ms Predict Reactivity Hu, Rat, Cow, Dog Tested Application WB Specificity This antibody is expected to recognize both reported isoforms (NP_055385.3; NP_001135765.1). Host Goat Clonality Polyclonal Isotype IgG Target Name ARFGAP3 Antigen Species Human Immunogen C-NGVVTSIQDRYGS Conjugation Un-conjugated Alternate Names ARF GAP 3; ADP-ribosylation factor GTPase-activating protein 3; ARFGAP1 Application Instructions Application table Application Dilution WB 1 - 3 µg/ml Application Note WB: Recommend incubate at RT for 1h. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 57 kDa Properties Form Liquid Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. Buffer Tris saline (pH 7.3), 0.02% Sodium azide and 0.5% BSA Preservative 0.02% Sodium azide Stabilizer 0.5% BSA Concentration 0.5 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed www.arigobio.com 1/2 before use. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Database links GeneID: 66251 Mouse Swiss-port # Q9D8S3 Mouse Background The protein encoded by this gene is a GTPase-activating protein (GAP) that associates with the Golgi apparatus and regulates the early secretory pathway of proteins.
    [Show full text]
  • Functional Characterization of Novel Human Arfgap3provided by Elsevier - Publisher Connector
    FEBS 24584 FEBS Letters 490 (2001) 79^83 View metadata, citation and similar papers at core.ac.uk brought to you by CORE Functional characterization of novel human ARFGAP3provided by Elsevier - Publisher Connector Xiaoqin Liua;b, Chenggang Zhanga, Guichun Xinga, Qingtang Chenb, Fuchu Hea;* aDepartment of Genomics and Proteomics, Beijing Institute of Radiation Medicine, Chinese National Human Genome Center at Beijing, 27 Taiping Road, Beijing 100850, PR China bDepartment of Neurology, First Teaching Hospital, Beijing University, Beijing 100034, PR China Received 10 October 2000; revised 3 January 2001; accepted 10 January 2001 First published online 22 January 2001 Edited by Felix Wieland Gcs1 [9], Mus musculus ASAP1 [10], R. norvegicus GIT1 [11], Abstract ADP ribosylation factors (ARFs) are critical in the vesicular trafficking pathway. ARF activity is controlled by R. norvegicus Pap [12], and S. cerevisiae Glo3 [13]. Moreover, GTPase-activating proteins (GAPs). We have identified recently the crystal structural and functional analysis of the complex a novel tentative ARF GAP derived from human fetal liver, of human ARF1 with rat ARF1 GAP was reported recently ARFGAP3 (originally named as ARFGAP1). In the present [14]. However, the knowledge about the complexity and im- study, we demonstrated that ARFGAP3 had GAP activity in portance of ARF GAP-directed vesicle transport, especially vitro and remarked that the GAP activity of ARFGAP3 was those from human, is still limited. regulated by phospholipids, i.e. phosphatidylinositol 4,5-diphos- Recently, we have identi¢ed a novel human ARFGAP, phate as agonist and phosphatidylcholine as antagonist. ARF- ARFGAP3 (originally named as ARFGAP1) [15]. ARFGAP3 GAP3 is a predominantly cytosolic protein, and concentrated in encodes a polypeptide of 516 amino acids with an ARF GAP the perinuclear region.
    [Show full text]
  • Genome-Wide Gene-Expression Patterns of Donor Kidney Biopsies Distinguish Primary Allograft Function
    Laboratory Investigation (2004) 84, 353–361 & 2004 USCAP, Inc All rights reserved 0023-6837/04 $25.00 www.laboratoryinvestigation.org Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function Peter Hauser1, Christoph Schwarz1, Christa Mitterbauer1, Heinz M Regele2, Ferdinand Mu¨ hlbacher3, Gert Mayer4, Paul Perco1, Bernd Mayer5, Timothy W Meyer6 and Rainer Oberbauer1 1Departments of Nephrology, 2Pathology and 3Transplant Surgery University of Vienna, Austria; 4Department of Nephrology, University of Innsbruck, Austria; 5Emergentec Data Analytics, Vienna, Austria and 6Department of Nephrology, Stanford University, Stanford, CA, USA Roughly 25% of cadaveric, but rarely living donor renal transplant recipients, develop postischemic acute renal failure, which is a main risk factor for reduced long-term allograft survival. An accurate prediction of recipients at risk for ARF is not possible on the basis of donor kidney morphology or donor/recipient demographics. We determined the genome-wide gene-expression pattern using cDNA microarrays in three groups of 36 donor kidney wedge biopsies: living donor kidneys with primary function, cadaveric donor kidneys with primary function and cadaveric donor kidneys with biopsy proven acute renal failure. The descriptive genes were characterized in gene ontology terms to determine their functional role. The validation of microarray experiments was performed by real-time PCR. We retrieved 132 genes after maxT adjustment for multiple testing that significantly separated living from cadaveric kidneys, and 48 genes that classified the donor kidneys according to their post-transplant course. The main functional roles of these genes are cell communication, apoptosis and inflammation. In particular, members of the complement cascade were activated in cadaveric, but not in living donor kidneys.
    [Show full text]
  • 9A˚Structure of the COPI Coat Reveals That the Arf1
    RESEARCH ARTICLE 9A˚ structure of the COPI coat reveals that the Arf1 GTPase occupies two contrasting molecular environments Svetlana O Dodonova1,2†, Patrick Aderhold3†, Juergen Kopp3, Iva Ganeva3, Simone Ro¨ hling3, Wim J H Hagen1, Irmgard Sinning3, Felix Wieland3, John A G Briggs1,4,5* 1Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany; 2Molecular Biology Department, Max Planck Institute for Biophysical Chemistry, Go¨ ttingen, Germany; 3Heidelberg University Biochemistry Center, Heidelberg University, Heidelberg, Germany; 4Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Heidelberg, Germany; 5MRC Laboratory of Molecular Biology, Cambridge, United Kingdom Abstract COPI coated vesicles mediate trafficking within the Golgi apparatus and between the Golgi and the endoplasmic reticulum. Assembly of a COPI coated vesicle is initiated by the small GTPase Arf1 that recruits the coatomer complex to the membrane, triggering polymerization and budding. The vesicle uncoats before fusion with a target membrane. Coat components are structurally conserved between COPI and clathrin/adaptor proteins. Using cryo-electron tomography and subtomogram averaging, we determined the structure of the COPI coat assembled on membranes in vitro at 9 A˚ resolution. We also obtained a 2.57 A˚ resolution crystal structure of bd-COP. By combining these structures we built a molecular model of the coat. We *For correspondence: john. additionally determined the coat structure in the presence of ArfGAP proteins that regulate coat [email protected] dissociation. We found that Arf1 occupies contrasting molecular environments within the coat, leading us to hypothesize that some Arf1 molecules may regulate vesicle assembly while others †These authors contributed regulate coat disassembly.
    [Show full text]
  • IQSEC1 Antibody (N-Terminus) Rabbit Polyclonal Antibody Catalog # ALS17128
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 IQSEC1 Antibody (N-Terminus) Rabbit Polyclonal Antibody Catalog # ALS17128 Specification IQSEC1 Antibody (N-Terminus) - Product Information Application IHC Primary Accession Q6DN90 Other Accession 9922 Reactivity Human, Mouse, Rat Host Rabbit Clonality Polyclonal Calculated MW 108314 Human Tonsil: Formalin-Fixed, IQSEC1 Antibody (N-Terminus) - Additional Information Paraffin-Embedded (FFPE) Gene ID 9922 Other Names IQSEC1, ARF-GEP100, ARFGEP100, Brefeldin A-resistant ARF-GEF2, BRAG2, IQ motif and Sec7 domain 1, KIAA0763, GEP100 Target/Specificity IQSEC1 antibody is human, mouse and rat reactive. At least four isoforms of IQSEC1 are known to exist. IQSEC1 antibody is Human Kidney: Formalin-Fixed, predicted to not cross-react with IQSEC2. Paraffin-Embedded (FFPE) Reconstitution & Storage PBS, 0.02% sodium azide. Long term: -20°C; IQSEC1 Antibody (N-Terminus) - Short term: +4°C. Avoid repeat freeze-thaw Background cycles. In addition to accelerate GTP gamma S Precautions binding by ARFs of all three classes, it appears IQSEC1 Antibody (N-Terminus) is for to function preferentially as a guanine research use only and not for use in diagnostic or therapeutic procedures. nucleotide exchange protein for ARF6, mediating internalisation of beta-1 integrin. IQSEC1 Antibody (N-Terminus) - IQSEC1 Antibody (N-Terminus) - Protein Information References Dunphy J.L.,et al.Curr. Biol. 16:315-320(2006). Name IQSEC1 (HGNC:29112) Nagase T.,et al.DNA Res. 5:277-286(1998). Someya A.,et al.Proc. Natl. Acad. Sci. U.S.A. Function 98:2413-2418(2001). Guanine nucleotide exchange factor for Dephoure N.,et al.Proc.
    [Show full text]
  • Genome-Wide Rnai Screen Reveals a Role for the ESCRT Complex in Rotavirus Cell Entry
    Genome-wide RNAi screen reveals a role for the ESCRT complex in rotavirus cell entry Daniela Silva-Ayalaa, Tomás Lópeza, Michelle Gutiérreza, Norbert Perrimonb, Susana Lópeza, and Carlos F. Ariasa,1 aDepartamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Colonia Chamilpa, Cuernavaca, Morelos 62210, Mexico; and bDepartment of Genetics, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115 Edited by Mary K. Estes, Baylor College of Medicine, Houston, TX, and approved May 3, 2013 (received for review March 14, 2013) Rotavirus (RV) is the major cause of childhood gastroenteritis described that the VP8 protein of human RV strain HAL1166 worldwide. This study presents a functional genome-scale analysis and the human RV strains belonging to the most frequent VP4 of cellular proteins and pathways relevant for RV infection using genotypes (P4 and P8) bind to A-type histo-blood group antigens RNAi. Among the 522 proteins selected in the screen for their (5, 6). Integrin 2β1 has also been reported to serve as an attach- ability to affect viral infectivity, an enriched group that partic- ment receptor for some RV strains (7), although this integrin, as ipates in endocytic processes was identified. Within these pro- well as integrins vβ3 and xβ2 and the heat-shock protein 70 teins, subunits of the vacuolar ATPase, small GTPases, actinin 4, (HSC70), have been implicated mostly in a postattachment in- and, of special interest, components of the endosomal sorting teraction of the virus that might be involved in cell internalization complex required for transport (ESCRT) machinery were found.
    [Show full text]